Yeah, we'd need more data. Because PD is such a low-incidence disease generally, any kind of uptick, even in the pre-60 cohort, would push the dial substantially. Are pre-60 cases, which I just found out trivially are at 4%, increasing substantially? Is 4% inclusive of a much older dataset? I'd venture that the answer is yes, but I have no idea.